In particular, BLM seems to be able to control the inflammation associated with SLE, resulting in a decrease in PBLs’, monocytes’, and total PBMCs’ autophagy and citrullination levels, and in lower IL-18 serum concentrations. This evidence concerns the gene IL18 and systemic lupus erythematosus.